Might Malaria Medicines Used for a Week Beginning Day 9 Help Prevent COVID-19 Hospitalizations? . by Alice B. Clagett

Written and posted on 26 February 2021

Dear Ones,

I note the malaria medicines hydroxychloroquine sulfate and chloroquine phosphate are being used in Latin America, Asia, and Africa to treat COVID-19. But I see it is not approved by the FDA here in the United States for COVID-19?

I note hydroxychloroquine sulfate is approved by the FDA to treat lupus and rheumatoid arthritis. I read that both these diseases have to do with autoimmune disease, which occurs when a person’s immune system mistakenly attacks is or her own body.

I read there is a turning point in COVID-19 at 10 to 12 days, where a person either starts to improve, or else the disease becomes quite serious. Could it be that the determining factor in recovery or serious illness at 10 to 12 days has to do with whether the autoimmune disease kicks in at that point?

If so, then it might be appropriate to use a brief course of hydroxychloroquine sulfate or chloroquine phosphate, starting, say, at day 9, and lasting, say, for a week? Might that help prevent COVID hospitalizations, I wonder?

In love, light and joy,
I Am of the Stars

…………………..

Creative Commons License
Except where otherwise noted, this work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
…………………………………………………….
…………………………………………………….

health, community health, COVID-19, COVID, coronavirus, Western medicine,

Comments?